NewslettersCancer Stem Cell NewsP4HB Maintains Wnt-Dependent Stemness in Glioblastoma Stem Cells as a Precision Therapeutic Target and Serum MarkerBy Jamie Kang - November 27, 20240360Using bioinformatics and experimental analysis, scientists identified P4HB, a protein disulfide isomerase, as a serum marker that maintains stemness in glioblastoma stem cells through the Wnt/β-catenin signaling pathway.[Oncogenesis]Full Article